Comparison of efficacy of oral and vaginal progesterone to prevent preterm birth in pregnant women with short cervix: Randomized controlled trial
Phase 4
Completed
- Conditions
- Preterm deliverycervical lengthprogesterone
- Registration Number
- TCTR20190324001
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 84
Inclusion Criteria
All pregnancy with 20-25 weeks of gestation women who visited ANC clinic at SPS Hospital
A singleton
Cervical length 25 mm or less by transvaginal ultrasound measure
Exclusion Criteria
History of allergy of progesterone
Fetal anomaly
Fetal aneuploidy
Cervical incompetence
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method preterm birth before 34 weeks until the patients delivery medical record of labor at Suspasittiprasong Hospital,preterm birth before 37 weeks until the patients delivery medical record of labor at Suspasittiprasong Hospital
- Secondary Outcome Measures
Name Time Method maternal obstatic complication After discharge from Suspasittiprasong Hospital due to delivery medical record at Suspasittiprasong Hospital,neonatal complication After discharge from Suspasittiprasong Hospital due to delivery medical record at Suspasittiprasong Hospital,change in cervical length after progesterone was used 4 weeks after the first measure at date of enrollment measure by transvaginal ultrasound